Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Comparative analysis of tumor-infiltrating lymphocytes in a syngeneic mouse model of oral cancer.

Judd NP, Allen CT, Winkler AE, Uppaluri R.

Otolaryngol Head Neck Surg. 2012 Sep;147(3):493-500. doi: 10.1177/0194599812442037. Epub 2012 Mar 19.

PMID:
22434099
[PubMed - indexed for MEDLINE]
2.

Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.

Kilinc MO, Aulakh KS, Nair RE, Jones SA, Alard P, Kosiewicz MM, Egilmez NK.

J Immunol. 2006 Nov 15;177(10):6962-73.

PMID:
17082611
[PubMed - indexed for MEDLINE]
Free Article
4.

Establishment of an orthotopic transplantable gastric cancer animal model for studying the immunological effects of new cancer therapeutic modules.

Shan YS, Fang JH, Lai MD, Yen MC, Lin PW, Hsu HP, Lin CY, Chen YL.

Mol Carcinog. 2011 Oct;50(10):739-50. doi: 10.1002/mc.20668. Epub 2010 Aug 24.

PMID:
20737421
[PubMed - indexed for MEDLINE]
5.

Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer.

Loddenkemper C, Hoffmann C, Stanke J, Nagorsen D, Baron U, Olek S, Huehn J, Ritz JP, Stein H, Kaufmann AM, Schneider A, Cichon G.

Cancer Sci. 2009 Jun;100(6):1112-7.

PMID:
19514119
[PubMed - indexed for MEDLINE]
6.
7.

Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.

Schirrmacher V, Schild HJ, Gückel B, von Hoegen P.

Immunol Cell Biol. 1993 Aug;71 ( Pt 4):311-26.

PMID:
7901150
[PubMed - indexed for MEDLINE]
Free Article
8.

TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.

Gao X, Zhu Y, Li G, Huang H, Zhang G, Wang F, Sun J, Yang Q, Zhang X, Lu B.

PLoS One. 2012;7(2):e30676. doi: 10.1371/journal.pone.0030676. Epub 2012 Feb 17.

PMID:
22363469
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.

Schwarz S, Butz M, Morsczeck C, Reichert TE, Driemel O.

J Oral Pathol Med. 2008 Sep;37(8):485-9. doi: 10.1111/j.1600-0714.2008.00641.x. Epub 2008 Mar 18.

PMID:
18355177
[PubMed - indexed for MEDLINE]
10.

Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.

Anichini A, Molla A, Vegetti C, Bersani I, Zappasodi R, Arienti F, Ravagnani F, Maurichi A, Patuzzo R, Santinami M, Pircher H, Di Nicola M, Mortarini R.

Cancer Res. 2010 Nov 1;70(21):8378-87. doi: 10.1158/0008-5472.CAN-10-2028. Epub 2010 Sep 21.

PMID:
20861189
[PubMed - indexed for MEDLINE]
Free Article
11.

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.

Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.

PMID:
19022917
[PubMed - indexed for MEDLINE]
12.

Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.

Pallandre JR, Brillard E, Créhange G, Radlovic A, Remy-Martin JP, Saas P, Rohrlich PS, Pivot X, Ling X, Tiberghien P, Borg C.

J Immunol. 2007 Dec 1;179(11):7593-604.

PMID:
18025205
[PubMed - indexed for MEDLINE]
Free Article
13.

Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins.

Bui JD, Uppaluri R, Hsieh CS, Schreiber RD.

Cancer Res. 2006 Jul 15;66(14):7301-9.

PMID:
16849580
[PubMed - indexed for MEDLINE]
Free Article
14.

Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.

Chang LY, Lin YC, Mahalingam J, Huang CT, Chen TW, Kang CW, Peng HM, Chu YY, Chiang JM, Dutta A, Day YJ, Chen TC, Yeh CT, Lin CY.

Cancer Res. 2012 Mar 1;72(5):1092-102. doi: 10.1158/0008-5472.CAN-11-2493. Epub 2012 Jan 26.

PMID:
22282655
[PubMed - indexed for MEDLINE]
Free Article
15.

Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.

Watanabe Y, Katou F, Ohtani H, Nakayama T, Yoshie O, Hashimoto K.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May;109(5):744-52. doi: 10.1016/j.tripleo.2009.12.015. Epub 2010 Mar 29.

PMID:
20303300
[PubMed - indexed for MEDLINE]
16.

Lack of effector cell function and altered tetramer binding of tumor-infiltrating lymphocytes.

Blohm U, Roth E, Brommer K, Dumrese T, Rosenthal FM, Pircher H.

J Immunol. 2002 Nov 15;169(10):5522-30.

PMID:
12421928
[PubMed - indexed for MEDLINE]
Free Article
17.

Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.

Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, Brasnu DF, Tartour E.

Clin Cancer Res. 2006 Jan 15;12(2):465-72.

PMID:
16428488
[PubMed - indexed for MEDLINE]
Free Article
18.

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.

Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.

Gastroenterology. 2007 Jun;132(7):2328-39. Epub 2007 Apr 14.

PMID:
17570208
[PubMed - indexed for MEDLINE]
19.

Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors.

Søndergaard H, Frederiksen KS, Thygesen P, Galsgaard ED, Skak K, Kristjansen PE, Odum N, Kragh M.

Cancer Immunol Immunother. 2007 Sep;56(9):1417-28. Epub 2007 Feb 7.

PMID:
17285290
[PubMed - indexed for MEDLINE]
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk